These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 29442042)

  • 41. TRIM59 Is a Novel Marker of Poor Prognosis and Promotes Malignant Progression of Ovarian Cancer by Inducing Annexin A2 Expression.
    Wang Y; Zhou Z; Wang X; Zhang X; Chen Y; Bai J; Di W
    Int J Biol Sci; 2018; 14(14):2073-2082. PubMed ID: 30585270
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Linc00152 promotes cancer progression in hepatitis B virus-associated hepatocellular carcinoma.
    Deng X; Zhao XF; Liang XQ; Chen R; Pan YF; Liang J
    Biomed Pharmacother; 2017 Jun; 90():100-108. PubMed ID: 28343069
    [TBL] [Abstract][Full Text] [Related]  

  • 43. MTBP Promotes the Invasion and Metastasis of Hepatocellular Carcinoma by Enhancing the MDM2-Mediated Degradation of E-Cadherin.
    Lu S; Zhou W; Wei H; He L; Li L
    Dig Dis Sci; 2015 Dec; 60(12):3681-90. PubMed ID: 26280083
    [TBL] [Abstract][Full Text] [Related]  

  • 44. MiR-26b inhibits hepatocellular carcinoma cell proliferation, migration, and invasion by targeting EphA2.
    Li H; Sun Q; Han B; Yu X; Hu B; Hu S
    Int J Clin Exp Pathol; 2015; 8(5):4782-90. PubMed ID: 26191168
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Metastasin leads to poor prognosis of hepatocellular carcinoma through partly inducing EMT.
    Zheng X; Gai X; Wu Z; Liu Q; Yao Y
    Oncol Rep; 2013 May; 29(5):1811-8. PubMed ID: 23483190
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Role of IQGAP3 in metastasis and epithelial-mesenchymal transition in human hepatocellular carcinoma.
    Shi Y; Qin N; Zhou Q; Chen Y; Huang S; Chen B; Shen G; Jia H
    J Transl Med; 2017 Aug; 15(1):176. PubMed ID: 28810875
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Fibulin-5 inhibits hepatocellular carcinoma cell migration and invasion by down-regulating matrix metalloproteinase-7 expression.
    Tu K; Dou C; Zheng X; Li C; Yang W; Yao Y; Liu Q
    BMC Cancer; 2014 Dec; 14():938. PubMed ID: 25494879
    [TBL] [Abstract][Full Text] [Related]  

  • 48. MicroRNA-24 increases hepatocellular carcinoma cell metastasis and invasion by targeting p53: miR-24 targeted p53.
    Chen L; Luo L; Chen W; Xu HX; Chen F; Chen LZ; Zeng WT; Chen JS; Huang XH
    Biomed Pharmacother; 2016 Dec; 84():1113-1118. PubMed ID: 27780140
    [TBL] [Abstract][Full Text] [Related]  

  • 49. NEAT1 promotes cell proliferation and invasion in hepatocellular carcinoma by negative regulating miR-613 expression.
    Wang Z; Zou Q; Song M; Chen J
    Biomed Pharmacother; 2017 Oct; 94():612-618. PubMed ID: 28783584
    [TBL] [Abstract][Full Text] [Related]  

  • 50. SKA3 Promotes tumor growth by regulating CDK2/P53 phosphorylation in hepatocellular carcinoma.
    Hou Y; Wang Z; Huang S; Sun C; Zhao J; Shi J; Li Z; Wang Z; He X; Tam NL; Wu L
    Cell Death Dis; 2019 Dec; 10(12):929. PubMed ID: 31804459
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Kinesin family member 2C promotes hepatocellular carcinoma growth and metastasis via activating MEK/ERK pathway.
    Ding Q; Jiang C; Zhou Y; Duan J; Lai J; Jiang M; Lin D
    Biosci Biotechnol Biochem; 2021 Oct; 85(11):2241-2249. PubMed ID: 34494081
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Clinical implication of Frizzled 2 expression and its association with epithelial-to-mesenchymal transition in hepatocellular carcinoma.
    Asano T; Yamada S; Fuchs BC; Takami H; Hayashi M; Sugimoto H; Fujii T; Tanabe KK; Kodera Y
    Int J Oncol; 2017 May; 50(5):1647-1654. PubMed ID: 28350091
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Characterization of the oncogenic activity of the novel TRIM59 gene in mouse cancer models.
    Valiyeva F; Jiang F; Elmaadawi A; Moussa M; Yee SP; Raptis L; Izawa JI; Yang BB; Greenberg NM; Wang F; Xuan JW
    Mol Cancer Ther; 2011 Jul; 10(7):1229-40. PubMed ID: 21593385
    [TBL] [Abstract][Full Text] [Related]  

  • 54. ANGPTL2 promotes tumor metastasis in hepatocellular carcinoma.
    Gao L; Ge C; Fang T; Zhao F; Chen T; Yao M; Li J; Li H
    J Gastroenterol Hepatol; 2015 Feb; 30(2):396-404. PubMed ID: 25090954
    [TBL] [Abstract][Full Text] [Related]  

  • 55. TRIM59 overexpression correlates with poor prognosis and contributes to breast cancer progression through AKT signaling pathway.
    Liu Y; Dong Y; Zhao L; Su L; Diao K; Mi X
    Mol Carcinog; 2018 Dec; 57(12):1792-1802. PubMed ID: 30175868
    [TBL] [Abstract][Full Text] [Related]  

  • 56. CCAT1 promotes hepatocellular carcinoma cell proliferation and invasion.
    Zhu H; Zhou X; Chang H; Li H; Liu F; Ma C; Lu J
    Int J Clin Exp Pathol; 2015; 8(5):5427-34. PubMed ID: 26191246
    [TBL] [Abstract][Full Text] [Related]  

  • 57. TIP30 mutant derived from hepatocellular carcinoma specimens promotes growth of HepG2 cells through up-regulation of N-cadherin.
    Jiang C; Pecha J; Hoshino I; Ankrapp D; Xiao H
    Cancer Res; 2007 Apr; 67(8):3574-82. PubMed ID: 17440068
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Silencing GTSE-1 expression inhibits proliferation and invasion of hepatocellular carcinoma cells.
    Guo L; Zhang S; Zhang B; Chen W; Li X; Zhang W; Zhou C; Zhang J; Ren N; Ye Q
    Cell Biol Toxicol; 2016 Aug; 32(4):263-74. PubMed ID: 27240802
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Downregulation of RFX1 predicts poor prognosis of patients with small hepatocellular carcinoma.
    Liu Y; Jiang P; Wang G; Liu X; Luo S
    Eur J Surg Oncol; 2018 Jul; 44(7):1087-1093. PubMed ID: 29764705
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Blocking transforming growth factor-beta up-regulates E-cadherin and reduces migration and invasion of hepatocellular carcinoma cells.
    Fransvea E; Angelotti U; Antonaci S; Giannelli G
    Hepatology; 2008 May; 47(5):1557-66. PubMed ID: 18318443
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.